These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8357203)

  • 1. An in vitro model for disease-specific immunotherapy in myasthenia gravis using soluble MHC class II bound to AChR-derived peptide.
    Nicolle MW; Vincent A; Sharma S; Nag B; Willcox N; Newsom-Davis J
    Ann N Y Acad Sci; 1993 Jun; 681():577-80. PubMed ID: 8357203
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune response gene control of lymphocyte proliferation induced by acetylcholine receptor-specific helper factor derived from lymphocytes of myasthenic mice.
    Christadoss P; Lindstrom JM; Talal N; Duvic CR; Kalantri A; Shenoy M
    J Immunol; 1986 Sep; 137(6):1845-9. PubMed ID: 2943805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-nicotinic receptor autoimmunity in myasthenia gravis. Establishment of specific T-helper cell lines and identification of sensitizing epitopes on the alpha-subunit.
    Hohlfeld R; Toyka K; Heininger K; Tzartos SJ; Walgrave SL; Protti P; Conti-Tronconi BM
    Monogr Allergy; 1988; 25():50-67. PubMed ID: 2459613
    [No Abstract]   [Full Text] [Related]  

  • 4. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
    Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
    Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholine receptor-specific human T-lymphocyte lines.
    Hohlfeld R; Toyka KV; Michels M; Heininger K; Conti-Tronconi B; Tzartos SJ
    Ann N Y Acad Sci; 1987; 505():27-38. PubMed ID: 2446551
    [No Abstract]   [Full Text] [Related]  

  • 6. Stimulation of autoimmune helper T lymphocytes from patients with myasthenia gravis with synthetic peptides of the acetylcholine receptor alpha subunit.
    Hohlfeld R; Toyka KV; Miner LL; Conti-Tronconi BM
    Ann N Y Acad Sci; 1988; 540():511-2. PubMed ID: 2462826
    [No Abstract]   [Full Text] [Related]  

  • 7. Complementary strategies to elucidate T helper cell epitopes in myasthenia gravis.
    Jung C; Stoeckle C; Wiesmüller KH; Laub R; Emmrich F; Jung G; Melms A
    J Neuroimmunol; 2008 Sep; 201-202():41-9. PubMed ID: 18649950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodominant regions for T helper-cell sensitization on the human nicotinic receptor alpha subunit in myasthenia gravis.
    Protti MP; Manfredi AA; Straub C; Howard JF; Conti-Tronconi BM
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7792-6. PubMed ID: 2145582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia gravis: recognition of a human autoantigen at the molecular level.
    Protti MP; Manfredi AA; Horton RM; Bellone M; Conti-Tronconi BM
    Immunol Today; 1993 Jul; 14(7):363-8. PubMed ID: 8363727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
    J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human acetylcholine receptor presentation in myasthenia gravis. DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules.
    Manfredi AA; Yuen MH; Moiola L; Protti MP; Conti-Tronconi BM
    J Immunol; 1994 Apr; 152(8):4165-74. PubMed ID: 7511671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation of endogenous acetylcholine receptor epitope by an MHC class II-transfected human muscle cell line to a specific CD4+ T cell clone from a myasthenia gravis patient.
    Baggi F; Nicolle M; Vincent A; Matsuo H; Willcox N; Newsom-Davis J
    J Neuroimmunol; 1993 Jul; 46(1-2):57-65. PubMed ID: 7689595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T-epitope repertoire on the human acetylcholine receptor alpha subunit in severe myasthenia gravis: a study with synthetic peptides.
    Manfredi AA; Protti MP; Wu XD; Howard JF; Conti-Tronconi BM
    Neurology; 1992 May; 42(5):1092-100. PubMed ID: 1374548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of helper T-cell specificity involved in the antibody response to the acetylcholine receptor.
    Tami JA; Krolick KA
    Ann N Y Acad Sci; 1988; 540():340-2. PubMed ID: 2462808
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance.
    Christadoss P; Shenoy M; Oshima M; Atassi MZ
    Adv Exp Med Biol; 1994; 347():65-75. PubMed ID: 7976734
    [No Abstract]   [Full Text] [Related]  

  • 16. Myasthenia gravis. T epitopes on the delta subunit of human muscle acetylcholine receptor.
    Protti MP; Manfredi AA; Wu XD; Moiola L; Howard JF; Conti-Tronconi BM
    J Immunol; 1991 Apr; 146(7):2253-61. PubMed ID: 1706391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
    Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
    J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies.
    Ohtsuru I; Matsuo H; Fukudome T; Suenaga A; Tsujihata M; Nagataki S
    Clin Exp Immunol; 1995 Dec; 102(3):462-7. PubMed ID: 8536358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes.
    Nicolle MW; Nag B; Sharma SD; Willcox N; Vincent A; Ferguson DJ; Newsom-Davis J
    J Clin Invest; 1994 Apr; 93(4):1361-9. PubMed ID: 7512979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myasthenia gravis].
    Kawaguchi N; Hattori T
    Nihon Rinsho; 2005 May; 63 Suppl 5():416-21. PubMed ID: 15954385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.